Zurueck zur Suche

Reporte zur Charge U005271

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OK 4 IN 2 CA 1 OH 1 KS 1 AR 1 MI 1

VAERS 2537166

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U005271

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
20.12.2022
Impfdatum
09.12.2022
Beginn
09.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

HCP reported RECOMBIVAX HB was administered to a patient on 09DEC2022 after the expiry date of 21NOV2022. No additional AE or PQC reported. No additional information provided.; HCP reported RECOMBIVAX HB was administered to a patient on 09DEC2022 after the expiry date of 21NOV2022. No additional AE or PQC reported. No additional information provided.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug allergies or reactions, and concomitant medications were unknown by the reporter. On 09-DEC-2022, the patient was vaccinated with an expired dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (route of administration, vaccination scheme frequency, and anatomical location were not provided; valid lot number U005271, with an expiration date of 21-NOV-2022) administered for prophylaxis (expired vaccine used). No additional adverse event (AE) or product quality complaint (PQC) were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2248240

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U005271

gering
Staat
CA
Alter
5,0
Geschlecht
M
Eingang
22.04.2022
Impfdatum
24.11.2021
Beginn
24.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dysphemia Dysstasia Feeling cold Nervous system disorder Speech disorder

Symptomtext

This was his second vaccine ever in his life. Again, hypotonic/hyporesponsive event right after the vaccine: he could not stand up. His eyes did not get bloodshot as they did with the dtap, however his speech got progressively worse. He stutters at the end of words, not all the time, sometimes more, sometimes less. Nonetheless, this is a progressive neurological problem and I am concerned. He never did this prior to vaccines in all of his years of speech therapy, he actually graduated from speech therapy in July 2021. Also he complains very frequently that his back is cold. Nowhere else on his body is cold, only his back (which is part of the neurological system). He never complained of this prior to vaccination. His pediatrician referred us to a pediatric neurologist, we are waiting to be seen next month.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dysphemia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Frequent sniffles/runny nose Frequent nose bleeds
Vorgeschichte
Born with a hernia
Andere Medikamente
multivitamin
Allergien
Walnuts-moderate Dairy-mild Eggs-mild Aloe Vera- moderate
Vorherige Impfungen
See VAERS E-Report number 832893 from 04/22/2022

VAERS 2187029

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U005271

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
18.03.2022
Impfdatum
03.03.2022
Beginn
03.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE; pediatric dose of RECOMBIVAX HB was inadvertently given to an adult; pediatric dose of RECOMBIVAX HB was inadvertently given to an adult; This spontaneous report was received from a nurse referring to an adult patient of unknown gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 03-MAR-2022, the patient was vaccinated with a pediatric dose of hepatitis b vaccine (recombinant) thimerosal free (RECOMBIVAX HB) 0.5 milliliter, lot number U005271, expiration date 21-NOV-2022 for prophylaxis (route of administration not provided) (incorrect dose administered and product administered to patient of inappropriate age). No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151729

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U005271

gering
Staat
OK
Alter
35,0
Geschlecht
M
Eingang
02.03.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Medication was stored improperly and not viable. Unknown at the time it was given. Unaware of any adverse reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2151717

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U005271

gering
Staat
OK
Alter
0,4
Geschlecht
F
Eingang
02.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Medication was stored improperly and not viable. Unknown at the time it was given. Unaware of any adverse reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2151701

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U005271

gering
Staat
OK
Alter
0,5
Geschlecht
M
Eingang
02.03.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product storage error

Symptomtext

Medication was stored improperly and not viable. Unknown at the time it was given. Unaware of any adverse reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2151681

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U005271

gering
Staat
OK
Alter
-
Geschlecht
M
Eingang
02.03.2022
Impfdatum
07.01.2022
Beginn
07.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Medication was stored improperly and not viable. Unknown at the time given. Unaware of any adverse reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2141825

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U005271

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
26.02.2022
Impfdatum
24.01.2022
Beginn
24.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

no additional AE reported; administered the RECOMBIVAX HB to a 17 year old patient instead of the VAQTA; patient was already fully vaccinated with the RECOMBIVAX HB; This spontaneous report was received from a medical assistant and refers to a 17-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 24-JAN-2022, the patient was vaccinated with hepatitis B vaccine (recombinant) thimerosal-free (RECOMBIVAX HB) 5 microgram (mcg)/0.5 ml, 0.5 ml, lot # U005271 with expiration date on 21-NOV-2022 (route of administration was not reported), for prophylaxis. The reporter stated that she administered the hepatitis B vaccine (recombinant) (RECOMBIVAX HB) instead of the hepatitis A vaccine, inactivated (VAQTA) (wrong product administered). The patient was already fully vaccinated with the hepatitis B vaccine (recombinant) (RECOMBIVAX HB) (extra dose administered). On the same day, after the error was discovered, the hepatitis A vaccine, inactivated (VAQTA) (25 units (U)/0.5ml, 0.5 ml, lot # U024504 with expiration date on 15-OCT-2022, for prophylaxis; route of administration not reported) was administered in the patient's opposite arm. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2058613

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge U005271

gering
Staat
KS
Alter
41,0
Geschlecht
F
Eingang
24.01.2022
Impfdatum
23.12.2021
Beginn
23.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered

Symptomtext

A pediatric Hepatitis B vaccine was given by nurse instead of an adult vaccine. Trying to correct error, nurse gave another pediatric Hep B thinking 2 pediatric would equal an adult. The patient still didn't get the equivalent of an adult dose with 2 of the pediatric doses. The patient has been notified and instructed that the 2nd dose that was given incorrectly would need to be repeated to fully complete the Hepatitis B series.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None known
Vorgeschichte
None known
Andere Medikamente
None known
Allergien
None known
Vorherige Impfungen
-

VAERS 1916737

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U005271

gering
Staat
AR
Alter
1,3
Geschlecht
F
Eingang
02.12.2021
Impfdatum
15.11.2021
Beginn
-
Tage bis Beginn
-
Dosis
4
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

No adverse reactions. This was just a 15 month child who received immunizations meant for a 6 mo old, so not all immunizations that were given were needed and o e missi g vaccine wasn't given. Mother was alerted and pt will receive their next needed vaccine at next visit

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Not ill at visit time. No adverse reaction, just given immunizations for 6 mo old instead of immunizations for 15 mo
Vorgeschichte
None
Andere Medikamente
None
Allergien
N.K.A.
Vorherige Impfungen
-

VAERS 1634760

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U005271

gering
Staat
MI
Alter
-
Geschlecht
F
Eingang
26.08.2021
Impfdatum
26.07.2021
Beginn
26.07.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Needle issue No adverse event

Symptomtext

No additional adverse effect reported; The vaccine was not fully administered due to the child moving the leg while getting the injection; needle was bent; This spontaneous report was received from a registered nurse, referring to a 3-year-old female patient. The patient's current condition included autism spectrum disorder. Information regarding the patient's pertinent drug reactions/allergies and concomitant medication was not provided. On 26-JUL-2021, the patient was vaccinated with the third dose of hepatitis b vaccine (recombinant)(RECOMBIVAX HB) lot # V005271, was evaluated and changed to the valid lot # U005271, expiration date 21-NOV-2022, 0.5 milliliter, intramuscular in the left thigh) for prophylaxis. During vaccine administration, the patient removed needle from leg due to movement, needle was bent (needle issue). The vaccine was not fully administered due to the child moving the leg while getting the injection (incorrect dose administered). The operator was a trained healthcare professional. There was no treatment for the events. Re-dosing was recommended, and the patient's mother declined at this time. No additional adverse effect reported. The outcome of the events was also reported as recovered. combinationproductreport: Yes; brandname: RECOMBIVAX HB SYRINGE (DEVICE); commondevicename: Hepatitis B Vaccine (Recombinant); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: U005271; expirationdate: 21-NOV-2022; deviceage and unit: 0 ; operatorofdevice: Other Health Care Professional; malfunction: Unknown; deviceusage: Unknown; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Autism spectrum disorder
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-